In the consolidated competitive landscape of rosacea therapeutics market, four leading companies account for over 75% share of the total market value, including Pfizer Inc., Teva Pharmaceutical Industries Ltd., Foamix Pharmaceuticals Ltd., and Bayer A.
The Rosacea Treatment Market To Upscale Amidst Technological Advancements
The FDA recently approved Oxymetazoline, employed in the rosacea-related persistent facial
erythema in adults.
Soolantra (topical ivermectin) received the FDA approval recently, for the use in the treatment
of inflammatory lesions of rosacea.
The FDA’s approval for a topical cream RHOFADE (Oxymetazoline Hydrochloride) paved the way
for the drug in the rosacea therapeutics, exclusively for persistent facial erythema in adults.
A tentative approval by the FDA has allowed the inclusion of Zenavod capsules (doxycycline) in
rosacea therapeutics. These capsules are particularly used against pustules and papules, i.e. the
specific inflammatory lesions associated with the condition in adults.
Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/18793
Foamix Pharmaceuticals Ltd.
SONOMA PHARMACEUTICALS, INC.
Nestlé Skin Health (Galderma S.A.)
Janssen Pharmaceuticals, Inc.
Teva Pharmaceuticals Company
While these FDA approvals for rosacea therapeutics were registered in 2017, the decently
growing rate of the introduction of new FDA-approved drugs is likely to provide a strong push
to the revenue expansion of rosacea therapeutics landscape.
With an expanding rosacea patient pool, most prominently in Europe and North America, the
revenue growth prospects for global rosacea therapeutics landscape appear to be on an
impressive trajectory over the coming years. In a new intelligence report published by
Persistence Market Research (PMR), the global sales of rosacea therapeutics are likely to
receive major benefits from the development of newer formulations of rosacea therapeutics,
especially alpha agonists.
Get To Know Methodology of Report
A senior research analyst at PMR says, “The largest business opportunity is created by the
increasing rosacea instances subsequentl